XOMA Co. (NASDAQ:XOMAP – Get Free Report) was the recipient of a significant decline in short interest during the month of May. As of May 29th, there was short interest totaling 84 shares, a decline of 72.7% from the May 14th total of 308 shares. Based on an average daily volume of 1,762 shares, the days-to-cover ratio is presently 0.0 days.
XOMA Trading Down 0.2%
Shares of XOMAP stock traded down $0.04 during trading hours on Friday, hitting $25.47. The stock had a trading volume of 480 shares, compared to its average volume of 2,000. XOMA has a one year low of $25.14 and a one year high of $30.00. The stock’s 50-day moving average price is $25.77 and its two-hundred day moving average price is $26.11.
About XOMA
XOMA Corporation (NASDAQ: XOMAP) is a clinical-stage biopharmaceutical company focused on the discovery and development of therapeutic antibodies for autoimmune and inflammatory diseases. The company leverages proprietary antibody-generation technologies—including ribosome display and phage display—to identify and optimize human monoclonal antibodies with high specificity and favorable pharmacological profiles.
Its lead clinical program is an interleukin-1 beta modulator being evaluated in patients with rare and severe inflammatory conditions.
Featured Articles
- Five stocks we like better than XOMA
- Adobe Stock Just Got Cheaper—Is Wall Street Missing the Story?
- 3 Dividend Stocks Under $50 That Pay You to Wait Out Inflation
- The 127-Gigawatt Problem: Why AI Needs Its Own Power
- ERock IPO: A $1.3B Power Play Solution
Receive News & Ratings for XOMA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for XOMA and related companies with MarketBeat.com's FREE daily email newsletter.
